Windlas Biotech Ltd. Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Windlas Biotech Limited is a pharmaceutical company engaged in the development, manufacturing, and marketing of generic and branded pharmaceutical products. Established in [year], the company has emerged as a prominent player in the Indian pharmaceutical industry, with a strong focus on quality and innovation.

Windlas Biotech Limited - Share Price

As a long-term stock investor, understanding the share price of Windlas Biotech Limited is crucial. Our pre-built screening tools offer real-time data and insights into the company's share price movement, enabling investors to make informed decisions. Whether you are tracking the stock's performance or analyzing historical trends, our tools provide a comprehensive analysis of the share price.

Windlas Biotech Limited - Balance Sheet

Windlas Biotech Limited's balance sheet is a comprehensive overview of the company's financial health. Using our premium features like the DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont Analysis, investors can calculate fair value and gain valuable insights into the company's financial position. We provide a downloadable version of the annual report, which includes detailed financial statements for a thorough analysis.

Windlas Biotech Limited - Annual Report

The annual report of Windlas Biotech Limited provides a comprehensive review of the company's performance, achievements, and future plans. It includes detailed financial statements, auditor's report, and management discussion and analysis. The annual report serves as a valuable resource for long-term stock investors, offering a deeper understanding of the company's operations and growth prospects.

Windlas Biotech Limited - Dividend

Dividends are an attractive aspect for long-term investors, providing a steady income stream. Windlas Biotech Limited's dividend history and policy can be explored through our platform. The company's commitment to rewarding shareholders is reflected in its dividend distribution. Investors can track historical dividend payments and make informed decisions accordingly.

Windlas Biotech Limited - Quarterly Results

Quarterly results play a crucial role in assessing a company's performance and its potential for growth. Our platform offers downloadable quarterly reports, enabling investors to analyze key financial metrics, such as revenue, earnings, and cash flow. With our tools, investors can delve deeper into the numbers and understand the underlying factors driving the company's quarterly results.

Windlas Biotech Limited - Stock Price

Tracking the stock price of Windlas Biotech Limited helps investors stay informed about market trends and make well-informed investment decisions. Our pre-built screening tools provide real-time data on the stock price, allowing investors to monitor the company's performance and identify potential buying or selling opportunities.

Windlas Biotech Limited - Price Chart

Price charts are powerful tools that visualize the historical price movement of a stock. Our platform provides interactive price charts for Windlas Biotech Limited, allowing investors to analyze trends, patterns, and support/resistance levels. By understanding the price chart, investors can enhance their technical analysis and gain insights into future stock price movements.

Windlas Biotech Limited - News

Staying informed about the latest news and developments regarding Windlas Biotech Limited is crucial for long-term stock investors. Our platform curates news articles related to the company, providing investors with a comprehensive view of market trends, regulatory updates, and corporate announcements. Timely access to accurate news can help investors stay ahead and make informed decisions.

Windlas Biotech Limited - Concall Transcripts

For investors seeking more in-depth information about the company's performance, concall transcripts are a valuable resource. Our platform offers downloadable concall transcripts of Windlas Biotech Limited, providing insights into management's views, strategies, and future plans. These transcripts enable investors to gain a deeper understanding of the company's operations, achievements, and challenges.

Windlas Biotech Limited - Investor Presentations

Investor presentations provide a summarized overview of a company's performance, growth, and future prospects. Windlas Biotech Limited's investor presentations can be accessed and downloaded from our platform, offering valuable insights into the company's business model, market position, and expansion plans. These presentations serve as a reliable source for long-term investors looking for an overview of the company's investment potential.

Windlas Biotech Limited - Promoters

The promoters of Windlas Biotech Limited play a significant role in shaping the company's growth strategy and vision. Understanding the background, experience, and shareholding of the promoters can give investors an insight into the company's direction. Our platform provides detailed information about the promoters of Windlas Biotech Limited, empowering investors with valuable knowledge to make informed investment decisions.

Windlas Biotech Limited - Shareholders

Analyzing the shareholding pattern of Windlas Biotech Limited can provide insights into the company's ownership structure and investor confidence. Our platform offers a detailed breakdown of the shareholders, including institutional investors, promoters, and retail investors. Understanding the composition of the shareholder base is crucial for long-term investors seeking to assess the company's stability and growth potential.

With our comprehensive range of tools, reports, and analysis, long-term stock investors can gain valuable insights into Windlas Biotech Limited. From monitoring the share price and analyzing the balance sheet to accessing annual reports and concall transcripts, our platform equips investors with the necessary information to make well-informed investment decisions. Explore our pre-built screening tools, premium features, and downloadable reports to make the most of your investing journey. 

Windlas Biotech Equity and Liabilities Analysis

Windlas Biotech's balance sheet reveals a consistent increase in total liabilities, from Rs 348.52 Cr. in March 2020 to Rs 625.59 Cr. by March 2024. A notable shift is observed in share capital adjustments, stabilizing around Rs 10.40 Cr. in March 2024 from an earlier expansion to Rs 10.90 Cr. in March 2022. Total reserves have shown a promising growth trajectory, enhancing from Rs 213.94 Cr. in March 2020 to Rs 439.89 Cr. in March 2024, signifying robust internal funding capabilities and profit retention.

Windlas Biotech Asset Management Insights

On the assets front, Windlas Biotech exhibited a strategic expansion in its net block from Rs 70.26 Cr. in March 2020 to Rs 179.05 Cr. by March 2024, indicating significant capital expenditure into fixed assets. However, investments showed a steep decline to zero by March 2024, suggesting a reallocation or utilization of funds elsewhere. Current assets experienced substantial growth, surging to Rs 431.24 Cr. by March 2024, highlighting effective asset management and liquidity improvement.

Windlas Biotech Debt and Borrowings Review

A remarkable reduction in borrowings from Rs 1.21 Cr. in March 2020 to a clean slate by March 2024 reflects Windlas Biotech's strategic financial management and a commitment to a debt-free status. The company's approach towards minimizing financial leverage is evident from this trend, emphasizing a preference for equity and internal funding over debt.

This analysis of Windlas Biotech's Standalone Balance Sheet highlights the company's fiscal management, asset growth, and strategic reallocation of resources over the years. The data also aligns with the critical aspects for investors looking into the pharmaceutical sector, NSE/BSE indices, IPOs, or other related stock market screening and analyses.